Rates of high-risk (HR)-MDS and acute myeloid leukemia (AML) progression were calculated from LR-MDS diagnosis to HR-MDS/AML diagnosis, or to last HR-MDS/AML follow-up date for pts who did not progress. Results: As of January 2, 2023, 11 pts remained on luspatercept treatment; 8 ...
The decision has been justified due to the current Omicron infection waves sweeping across most of the world, and while recent studies place Omicron as a less severe variant, its extremely high infection rates should still give decision makers pause. Interestingly, the ESA still hasn't confirmed ...
Disparities in under five mortality rates in Kisesa Health and Demographic surveillance site: Evidence from women household surveyKagoye, SophiaUrassa, MarkBoerma, TiesTodd, JimMangya, CharlesTanzania Journal of Health Research